Nelipepimut-S: Phase III discontinued

Galena discontinued the double-blind, placebo-controlled, international Phase III PRESENT trial comparing intradermal NeuVax plus intradermal Leukine sargramostim vs. Leukine alone at an IDMC’s recommendation based on a planned interim futility analysis. Dr. Reddy’s has exclusive rights to develop and commercialize NeuVax in India (see BioCentury, Jan. 20, 2014). ...